Celularity Inc [NASDAQ: CELU] stock went on an upward path that rose over 10.71% on Tuesday, amounting to a one-week price increase of more than 31.22%.
Over the last 12 months, CELU stock rose by 19.23%. The one-year Celularity Inc stock forecast points to a potential upside of 90.08. The average equity rating for CELU stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $59.40 million, with 22.55 million shares outstanding and 13.81 million shares in the current float. Compared to the average trading volume of 73.40K shares, CELU stock reached a trading volume of 7655950 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Celularity Inc [CELU]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CELU shares is $25.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CELU stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Celularity Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on January 30, 2023. The new note on the price target was released on December 22, 2022, representing the official price target for Celularity Inc stock. Previously, the target price had yet another raise to $15, while H.C. Wainwright analysts kept a Buy rating on CELU stock.
The Price to Book ratio for the last quarter was 6.33, with the Price to Cash per share for the same quarter was set at 0.03.
CELU Stock Performance Analysis:
Celularity Inc [CELU] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 31.22. With this latest performance, CELU shares gained by 40.91% in over the last four-week period, additionally plugging by 14.81% over the last 6 months – not to mention a rise of 19.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CELU stock in for the last two-week period is set at 66.94, with the RSI for the last a single of trading hit 0.20, and the three-weeks RSI is set at 0.20 for Celularity Inc [CELU]. The present Moving Average for the last 50 days of trading for this stock 1.98, while it was recorded at 2.22 for the last single week of trading, and 2.06 for the last 200 days.
Insight into Celularity Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Celularity Inc [CELU] shares currently have an operating margin of -71.10% and a Gross Margin at 57.74%. Celularity Inc’s Net Margin is presently recorded at -106.77%.
Return on Equity for this stock declined to -25.28%, with Return on Assets sitting at -25.28%.
Celularity Inc [CELU] Institutonal Ownership Details
There are presently around $14.66%, or 30.07% of CELU stock, in the hands of institutional investors. The top three institutional holders of CELU stocks are: VANGUARD GROUP INC with ownership of 0.5 million shares, which is approximately 2.289%. GEODE CAPITAL MANAGEMENT, LLC, holding 0.14 million shares of the stock with an approximate value of $$0.44 million in CELU stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$0.28 million in CELU stock with ownership which is approximately 0.4153%.
